Double ratio

The endogenous fluorophore PpIX labels cells in a rat brain tumor (left), but the fluorescence is absent after surgery to resect the tumor (right). Credit: Brian Wilson, University of Toronto" />The endogenous fluorophore PpIX labels cells in a rat brain tumor (left), but the fluorescence is absent after surgery to resect the tumor (right). Credit: Brian Wilson, University of Toronto

Written byRichard Gaughan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researcher:

Brian Wilson, Professor of Medical Physics, University of Toronto

Project:

Identifying and quantifying brain-tumor tissue to allow surgeons who are resecting a tumor to determine if any cancerous cells remain

Problem:

Wilson encountered a trifecta of confounding factors that often plague in vivo fluorescence: Background autofluorescence masks the signal; optical absorption and scattering can reduce both excitation and emission intensity; and changes in position, angle, and distance of the light source and camera all influence the measured intensity.

Solution:

Wilson developed a protocol that compensates for all three problems at once. He harnesses an endogenous fluorophore, protoporphyrin-IX (PpIX), to act as his fluorescent marker. PpIX has a very low native presence in the brain, so he first washes the region of interest with 5-aminolevulinic acid (ALA); the ALA triggers an increase in the cancer cells' metabolism, which then boosts their levels of PpIX. The tissues thus express their own ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies